Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Gastroenterology Research and Practice|October 29, 2015
Recurrent Thrombotic Events after Discontinuation of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort StudyNicoletta Riva, Walter Ageno, Daniela Poli, et al.
Blood Transfusion = Trasfusione Del Sangue|November 13, 2018
Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensusMariasanta Napolitano, Giorgia Saccullo, Marco Marietta, et al.
Thrombosis Research|April 16, 2014
Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria phenotype in patients with splanchnic vein thrombosisWalter Ageno, Francesco Dentali, Valerio De Stefano, et al.
American Journal of Hematology|February 25, 2016
Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA studyFrancesco Zaja, Wilma Barcellini, Silvia Cantoni, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 5, 2010
The impact of antithrombotic prophylaxis on infectious complications in cancer patients with central venous catheters: an observational studyDaniele Fagnani, Alessandro Bertolini, Laura Catena, et al.
Thyroid : Official Journal of the American Thyroid Association|June 24, 2026
Targeted Therapy-Induced Erythrocytosis in Thyroid Cancers: An Underrecognized Safety Signal from a Retrospective StudySilvia Marchesi, Rebecca Romanò, Andrea Spagnoletti, et al.
Journal of Thrombosis and Haemostasis : JTH|November 16, 2024
Bortezomib for rituximab-refractory immune-mediated thrombotic thrombocytopenic purpura in the caplacizumab era: an Italian multicenter studyJuri Alessandro Giannotta, Andrea Artoni, Ilaria Mancini, et al.
British Journal of Haematology|February 22, 2021
Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective studyElisa Lucchini, Francesca Palandri, Stefano Volpetti, et al.
Thrombosis Research|November 30, 2019
Management of elderly patients with immune thrombocytopenia: Real-world evidence from 451 patients older than 60 yearsFrancesca Palandri, Cristina Santoro, Monica Carpenedo, et al.
American Journal of Hematology|October 7, 2017
Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centersSilvia Cantoni, Monica Carpenedo, Maria Gabriella Mazzucconi, et al.
Pageof 4